Asasantin

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

60 API Suppliers, 26 USDMF, 9 CEP/COS, 6 JDMF, 1 EU WC, 4 KDMF, 31 NDC API, 29 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

34 Drugs in Development

34 Drugs in Development

FINISHED DOSAGE FORMULATIONS

446 FDF Dossiers, 117 FDA Orange Book, 110 Europe, 90 Canada, 8 Australia, 25 South Africa, 96 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG, TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CAPSULE;ORAL - 325MG;50MG;40MG;30MG, TABLET, DELAYED RELEASE;ORAL - 325MG;40MG, TABLET, DELAYED RELEASE;ORAL - 81MG;40MG, TABLET;ORAL - 250MG;250MG;65MG, CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 Minakem, 3 Evonik, 13 Rochem International Inc, 31 SPI Pharma, 2 Seqens, 24 DKSH, 3 Jai Radhe Sales, 3 Pharm-RX Chemical, 8 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 17 Gangwal Healthcare, 16 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 15 Actylis, 2 Aeon Procare, 3 Alcedo Pharmachem, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 40 BASF, 1 Bioplus Life Sciences, 3 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 3 Doshion Polyscience, 3 Finar, 16 Gangwal Chemicals, 17 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 40 Kerry, 5 Kima Chemical, 6 Lonza Capsugel, 24 Microlex e.U, 1 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 4 Novo Excipients, 5 Pharmatrans-Sanaq, 12 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 47 Roquette, 19 Seppic, 8 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 4 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Vertellus, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

131 Fillers, Diluents & Binders, 89 Coating Systems & Additives, 57 Thickeners and Stabilizers, 56 Direct Compression, 50 Controlled & Modified Release, 50 Solubilizers, 49 Disintegrants & Superdisintegrants, 46 Taste Masking, 38 Parenteral, 37 Granulation, 34 Topical, 33 Film Formers & Plasticizers, 31 Lubricants & Glidants, 26 Chewable & Orodispersible Aids, 23 Co-Processed Excipients, 16 Emulsifying Agents, 14 API Stability Enhancers, 12 Surfactant & Foaming Agents, 11 Rheology Modifiers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

10 DATA COMPILATION #PharmaFlow, 183 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 70 Finished Drug Prices, 10 Annual Reports

MARKET PLACE

53 APIs, 43 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 1 USP, 1 JP, 8 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 205103 / DOSAGE - TABLET, DELAYED RELEASE;ORAL - 325MG;40MG

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
aspirin(UNII: R16CO5Y76E) (aspirin - UNII:R16CO5Y76E)	aspirin	81mg \| 325mg
omeprazole(UNII: KG60484QX9) (omeprazole - UNII:KG60484QX9)	omeprazole	40mg \| 40mg

Inactive Ingredients

Ingredient Name	Innovida Phamaceutique Corporation
carnauba wax(R12CBM0EIZ)
FD&C blue no. 2(L06K8R7DQK)
ferric oxide yellow(EX438O2MRT)
glyceryl monostearate(230OU9XXE4)
HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO)
methacrylic acid - ethyl acrylate copolymer (1:1) type A(NX76LV5T8J)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
polydextrose(VH2XOU12IE)
POLYETHYLENE GLYCOL, UNSPECIFIED(3WJQ0SDW1A)
polysorbate 80(6OZP39ZG8H)
POVIDONE, UNSPECIFIED(FZ989GH94E)
SILICON DIOXIDE(ETJ7Z6XBU4)
sodium phosphate, dibasic, anhydrous(22ADO53M6F)
STARCH, CORN(O8232NY3SJ)
stearic acid(4ELV7Z65AP)
talc(7SEV7J4R1U)
titanium dioxide(15FIX9V2JP)
triacetin(XHX3C3X673)
triethyl citrate(8Z96QXD6UM)

Drug Product Composition: Asasantin

Asasantin

Asasantin

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

60 API Suppliers

26 USDMF

9 CEP/COS

6 JDMF

1 EU WC

4 KDMF

31 NDC API

29 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

34 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Exports

FDF Imports

FINISHED DOSAGE FORMULATIONS

446 FDF Dossiers

117 FDA Orange Book

110 Europe

90 Canada

8 Australia

25 South Africa

96 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CAPSULE;ORAL - 356.4MG;30MG;16MG

TABLET;ORAL - 325MG;50MG;40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CAPSULE;ORAL - 325MG;50MG;40MG;30MG

TABLET, DELAYED RELEASE;ORAL - 325MG;40MG

TABLET, DELAYED RELEASE;ORAL - 81MG;40MG

TABLET;ORAL - 250MG;250MG;65MG

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 325MG;50MG;40MG

RELATED EXCIPIENT COMPANIES

2 Minakem

3 Evonik

13 Rochem International Inc

31 SPI Pharma

2 Seqens

24 DKSH

3 Jai Radhe Sales

3 Pharm-RX Chemical

8 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

17 Gangwal Healthcare

16 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

15 Actylis

2 Aeon Procare

3 Alcedo Pharmachem

12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

40 BASF

1 Bioplus Life Sciences

3 Clariant

15 Corel Pharma Chem

7 DFE Pharma

3 Doshion Polyscience

3 Finar

16 Gangwal Chemicals

17 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

40 Kerry

5 Kima Chemical

6 Lonza Capsugel

24 Microlex e.U

1 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

4 Novo Excipients

5 Pharmatrans-Sanaq

TABLET;ORAL - 325MG;50MG;40MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CAPSULE, EXTENDED RELEASE;ORAL - 25MG;200MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons